Evolus Insider Sells $14,815 in Shares

Rui Avelar, an Evolus insider, sold 3,119 shares of the company's stock.

Mar. 21, 2026 at 12:42pm

Rui Avelar, an insider at Evolus, Inc. (NASDAQ:EOLS), sold 3,119 shares of the company's stock on Friday, March 20th. The shares were sold at an average price of $4.75, for a total value of $14,815.25. Following the sale, Avelar still owns 427,423 shares in the company, valued at $2,030,259.25.

Why it matters

Insider trading activity can provide insights into a company's performance and the sentiment of its leadership. This sale by an Evolus insider may signal potential concerns about the company's outlook or could simply be part of routine portfolio management.

The details

Rui Avelar, an Evolus insider, sold 3,119 shares of the company's stock on March 20th at an average price of $4.75 per share. This transaction resulted in total proceeds of $14,815.25 for Avelar. Following the sale, Avelar still owns 427,423 shares in Evolus, valued at $2,030,259.25.

  • Rui Avelar sold 3,119 shares on Friday, March 20th.
  • Rui Avelar also sold 29,996 shares on Tuesday, March 17th.
  • Rui Avelar sold 2,261 shares on Monday, December 22nd.

The players

Rui Avelar

An insider at Evolus, Inc. (NASDAQ:EOLS).

Evolus, Inc.

A specialty pharmaceutical company focused on medical aesthetics, headquartered in Newport Beach, California.

Got photos? Submit your photos here. ›

The takeaway

This insider sale by Rui Avelar may indicate potential concerns about Evolus' outlook, though it could also be part of routine portfolio management. Investors should continue to monitor the company's performance and any further insider trading activity.